NSIM
RNAC icon

North Star Investment Management’s Cartesian Therapeutics RNAC Stock Holding History

North Star Investment Management’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Buy
+1,084
New +$8.03K ﹤0.01% 1042

Other funds holding RNAC

FA
Fedenia Advisers Madison, Wisconsin $421M AUM 96.46% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

North Star Investment Management's RNAC Position: Q2 2026 in Review

North Star Investment Management opened a new position in Cartesian Therapeutics (RNAC) in Q2 2026: 1,084 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #1042 among its holdings.

17 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • North Star Investment Management held 1,084 shares of Cartesian Therapeutics worth $11.3K as of Q2 2026.
  • Cartesian Therapeutics was a new North Star Investment Management position in Q2 2026.
  • Cartesian Therapeutics made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1042 holding.
  • 17 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.